vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Rithm Capital Corp. (RITM). Click either name above to swap in a different company.

Rithm Capital Corp. is the larger business by last-quarter revenue ($828.2M vs $665.5M, roughly 1.2× Natera, Inc.). Rithm Capital Corp. runs the higher net margin — 13.2% vs 7.1%, a 6.1% gap on every dollar of revenue. On growth, Rithm Capital Corp. posted the faster year-over-year revenue change (508.5% vs 39.8%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -17.9%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Rithm Capital Corp. (Rithm) is an American investment management company headquartered in New York that focuses on real estate and alternative investments.

NTRA vs RITM — Head-to-Head

Bigger by revenue
RITM
RITM
1.2× larger
RITM
$828.2M
$665.5M
NTRA
Growing faster (revenue YoY)
RITM
RITM
+468.7% gap
RITM
508.5%
39.8%
NTRA
Higher net margin
RITM
RITM
6.1% more per $
RITM
13.2%
7.1%
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-17.9%
RITM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NTRA
NTRA
RITM
RITM
Revenue
$665.5M
$828.2M
Net Profit
$47.3M
$109.5M
Gross Margin
Operating Margin
-3.4%
29.9%
Net Margin
7.1%
13.2%
Revenue YoY
39.8%
508.5%
Net Profit YoY
187.9%
27.7%
EPS (diluted)
$0.36
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
RITM
RITM
Q1 26
$828.2M
Q4 25
$665.5M
$1.5B
Q3 25
$592.2M
$1.1B
Q2 25
$546.6M
$1.2B
Q1 25
$501.8M
$768.4M
Q4 24
$476.1M
$2.1B
Q3 24
$439.8M
$619.5M
Q2 24
$413.4M
$1.2B
Net Profit
NTRA
NTRA
RITM
RITM
Q1 26
$109.5M
Q4 25
$47.3M
$85.0M
Q3 25
$-87.5M
$221.5M
Q2 25
$-100.9M
$311.7M
Q1 25
$-66.9M
$78.8M
Q4 24
$-53.8M
$290.2M
Q3 24
$-31.6M
$121.7M
Q2 24
$-37.5M
$235.6M
Operating Margin
NTRA
NTRA
RITM
RITM
Q1 26
29.9%
Q4 25
-3.4%
13.8%
Q3 25
-16.5%
21.4%
Q2 25
-20.2%
25.2%
Q1 25
-15.8%
7.4%
Q4 24
-13.6%
23.8%
Q3 24
-8.9%
7.3%
Q2 24
-10.6%
23.6%
Net Margin
NTRA
NTRA
RITM
RITM
Q1 26
13.2%
Q4 25
7.1%
5.7%
Q3 25
-14.8%
20.0%
Q2 25
-18.5%
25.6%
Q1 25
-13.3%
10.3%
Q4 24
-11.3%
14.0%
Q3 24
-7.2%
19.7%
Q2 24
-9.1%
19.2%
EPS (diluted)
NTRA
NTRA
RITM
RITM
Q1 26
$0.12
Q4 25
$0.36
$0.09
Q3 25
$-0.64
$0.35
Q2 25
$-0.74
$0.53
Q1 25
$-0.50
$0.07
Q4 24
$-0.41
$0.50
Q3 24
$-0.26
$0.20
Q2 24
$-0.30
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
RITM
RITM
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$9.1B
Total Assets
$2.4B
$53.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
$1.8B
Q3 25
$1.0M
$1.6B
Q2 25
$16.0M
$1.6B
Q1 25
$17.8M
$1.5B
Q4 24
$22.7M
$1.5B
Q3 24
$29.5M
$1.6B
Q2 24
$90.3M
$1.2B
Total Debt
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
$35.4B
Q3 25
$32.2B
Q2 25
$31.2B
Q1 25
$32.2B
Q4 24
$32.6B
Q3 24
$29.6B
Q2 24
$30.1B
Stockholders' Equity
NTRA
NTRA
RITM
RITM
Q1 26
$9.1B
Q4 25
$1.7B
$8.4B
Q3 25
$1.3B
$8.5B
Q2 25
$1.2B
$7.9B
Q1 25
$1.2B
$7.8B
Q4 24
$1.2B
$7.8B
Q3 24
$878.5M
$7.7B
Q2 24
$836.5M
$7.3B
Total Assets
NTRA
NTRA
RITM
RITM
Q1 26
$53.4B
Q4 25
$2.4B
$53.1B
Q3 25
$1.8B
$47.2B
Q2 25
$1.8B
$44.3B
Q1 25
$1.7B
$45.3B
Q4 24
$1.7B
$46.0B
Q3 24
$1.6B
$42.3B
Q2 24
$1.5B
$42.0B
Debt / Equity
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
4.20×
Q3 25
3.79×
Q2 25
3.92×
Q1 25
4.14×
Q4 24
4.18×
Q3 24
3.87×
Q2 24
4.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
RITM
RITM
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
$73.9M
$-114.6M
Q3 25
$59.4M
$-2.0B
Q2 25
$37.6M
$-557.1M
Q1 25
$44.5M
$1.4B
Q4 24
$52.9M
$-1.8B
Q3 24
$51.8M
$768.1M
Q2 24
$4.0M
$-55.7M
Free Cash Flow
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
$37.8M
Q3 25
$37.0M
Q2 25
$11.7M
Q1 25
$22.6M
Q4 24
$34.8M
Q3 24
$35.5M
Q2 24
$-7.7M
FCF Margin
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
5.7%
Q3 25
6.2%
Q2 25
2.1%
Q1 25
4.5%
Q4 24
7.3%
Q3 24
8.1%
Q2 24
-1.9%
Capex Intensity
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
5.4%
Q3 25
3.8%
Q2 25
4.7%
Q1 25
4.3%
Q4 24
3.8%
Q3 24
3.7%
Q2 24
2.8%
Cash Conversion
NTRA
NTRA
RITM
RITM
Q1 26
Q4 25
1.56×
-1.35×
Q3 25
-9.22×
Q2 25
-1.79×
Q1 25
18.03×
Q4 24
-6.04×
Q3 24
6.31×
Q2 24
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NTRA
NTRA

Segment breakdown not available.

RITM
RITM

Servicing revenue, net$375.1M45%
Other$234.9M28%
Gain on originated residential mortgage loans, held-for-sale, net$195.0M24%
Other revenue$23.3M3%

Related Comparisons